Meitheal Pharmaceuticals has Regadenoson Injection Now Available

Share Facebook icon Twitter icon Linkedin icon

Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Regadenoson Injection, 0.4 mg/5 mL pre-filled syringe.

Meitheal will offer Regadenoson Injection in a carton of 1 syringe.


Regadenoson Injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. For full prescribing information, please click on the following link.


Learn more about Regadenoson Injection Now Available

This Website Uses Cookies

This website uses cookies to help us give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can read more about our use of cookies in our Privacy Policy.

Accept cookies Reject cookies